Alexza Pharmaceuticals Inc. 3 SEC Filings

Filed On	Filing
03 Nov 2014	Form 3: Grupo Ferrer Internacional, S.a., 10% owner Holds 2,241,935 shares of Common Stock
30 Jun 2014	Form 3: Kamemoto Edwin S, SVP, Regulatory Affairs Holds 24,737 shares of Common Stock
26 Feb 2014	Form 3: Lippe Robert A, EVP, Operations & COO Holds 0 shares of Common Stock
13 Mar 2013	Form 3: Schineller Peter W., SVP and CCO Holds 0 shares of Common Stock
03 Jan 2013	Form 3: Buchi J Kevin, Director Holds 0 shares of Common Stock
31 Dec 2012	Form 3: Lansdowne Partners Austria Gmbh, 10% owner Holds 1,572,866 shares of Common Stock, $0.0001 par value per share
30 Jul 2012	Form 3: Moreland Darl, SVP, Quality Holds 11,908 shares of Common Stock
09 Feb 2012	Form 3: Occitan Capital Management Inc., 10% owner and 1 other Holds 3,548,208 shares of Common Stock, par value $0.0001
20 Jan 2012	Form 3: Occitan Capital Management Inc., 10% owner and 1 other Holds 3,548,208 shares of Common Stock, par value $0.0001
22 Jul 2010	Form 3: Turner Joseph L, Director Holds 10,504 shares of Common Stock
20 May 2010	Form 3: Oki Mark K, VP Fin, Controller & PAO Holds 61,085 shares of Common Stock
25 Sep 2009	Form 3: Busser Andrew L, Director Holds 0 shares of Common Stock
08 Sep 2009	Form 3: Symphony Capital Partners Lp, 10% owner and 5 others Holds 6,724,000 shares of Common Stock, par value $0.0001 per share
27 Feb 2008	Form 3: Simms Michael J, SVP, Operations & Manufact
20 Dec 2007	Form 3: Barron Hal, Director Holds 0 shares of Common Stock
13 Mar 2007	Form 3: Tebbutt Anthony G, Sr VP, Corp Strategy/Bus Dev.
08 Mar 2006	Form 3: Fhm III, Llc, 10% owner and 5 others
08 Mar 2006	Form 3: Pakianathan Deepika, Director
08 Mar 2006	Form 3: Mario Ernest, Director Holds 18,181 shares of Common Stock
08 Mar 2006	Form 3: Read J Leighton, Director

Comments